Prevented Sudden Cardiac Death and Neurologic Recovery in Inherited Heart Diseases

Juan P Hernández Del Rincón1,2,3, Mari C Olmo Conesa3,4, Ana Rodríguez Serrano4

  • 1Instituto de Medicina Legal y Ciencias Forenses, Murcia, Spain.

Insights

Sudden cardiac death (SD) in inherited cardiovascular diseases remains a challenge. While a fifth of cardiac arrests were resuscitated, with good neurological recovery in two-thirds, preventing SD requires further advancements.

Area of Science:

  • Cardiology
  • Genetics
  • Neurology

Background:

  • Inherited cardiovascular diseases are a significant cause of sudden cardiac death (SD).
  • Risk scores and automated external defibrillators aid in identifying high-risk patients and improving resuscitation.
  • Quantifying prevented SD and neurological recovery is crucial for patient outcomes.

Purpose of the Study:

  • To quantify prevented sudden cardiac death (SD) in patients with inherited cardiovascular diseases.
  • To assess the neurological recovery of patients who experienced resuscitated cardiac arrest (RCA).

Main Methods:

  • Prospective collection of 257 cases of non-ischemic SD (2009-2017).
  • Analysis of epidemiological, clinical, and autopsy data for 204 deceased individuals and 53 cases of resuscitated cardiac arrest (RCA).
  • Definition of prevented SD as RCA plus appropriate implantable cardioverter-defibrillator (ICD) therapy.

Main Results:

  • Cardiomyopathy and channelopathy diagnosed in 58.0% and 18.7% of cases, respectively.
  • Female sex and channelopathy were associated with successful resuscitation.
  • Prevented SD rate was low (mean 35.6%); 60.4% of RCA cases had good neurological outcome, associated with shorter resuscitation time.

Conclusions:

  • Approximately 20% of non-ischemic cardiac arrests were successfully resuscitated.
  • Female sex and channelopathies were more common in resuscitated cardiac arrest patients.
  • Two-thirds of resuscitated cardiac arrest patients achieved good neurological recovery.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
124
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.2K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
106
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
453
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
104
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
122